You have 9 free searches left this month | for more free features.

Tuberculosis disease development

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

New Stool Based qPCR for Diagnosis of Tuberculosis in Children

Recruiting
  • Tuberculosis
  • Diagnoses Disease
    • Manhiça, Maputo, Mozambique
    • +2 more
    May 4, 2022

    Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,

    Active, not recruiting
    • Infections and Infestations
    • Pulmonary Tuberculosis
    • Tembisa, Gauteng, South Africa
    • +4 more
    Sep 13, 2022

    Tuberculosis, Adherence, Patient, Adherence, Medication Trial in Nairobi (Keheala Mobile Health Platform and Behavioral

    Completed
    • Tuberculosis
    • +3 more
    • Keheala Mobile Health Platform and Behavioral Interventions
    • +3 more
    • Nairobi, Kenya
      Kenya National TB Program
    Jan 6, 2022

    Tuberculosis Trial in Worldwide (FLOW-TB Next-generation LAM, TAM-TB, Host Response Cartridge)

    Recruiting
    • Tuberculosis
    • FLOW-TB Next-generation LAM
    • +13 more
    • Vellore, India
    • +10 more
    Dec 8, 2022

    Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,

    Active, not recruiting
    • Tuberculosis, Multidrug-Resistant
    • +2 more
    • Tbilisi, Georgia
    • +11 more
    Feb 14, 2022

    Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG

    Recruiting
    • Tuberculosis, Multidrug-Resistant
    • +5 more
    • Bedaquiline 100 MG
    • +4 more
    • Pune, India
    • +9 more
    Mar 2, 2022

    Tuberculosis, Diagnostics, Global Health Trial in Maputo, Cape Town, Kampala (Oral swab molecular testing, Automated Cough Sound

    Not yet recruiting
    • Tuberculosis
    • +2 more
    • Oral swab molecular testing
    • +3 more
    • Maputo, Mozambique
    • +2 more
    Aug 9, 2023

    Pulmonary Tuberculosis Trial in Rio de Janeiro, Rio De Janeiro (Standard care plus pulmonary rehabilitation, Standard Care)

    Recruiting
    • Pulmonary Tuberculosis
    • Standard care plus pulmonary rehabilitation
    • Standard Care
    • Rio de Janeiro, Brazil
    • +1 more
    Nov 7, 2023

    Kit for Diagnosis of Tuberculosis Disease

    Not yet recruiting
    • Tuberculosis, Pulmonary
    • +2 more
    • NanoDetect-TB
    • (no location specified)
    Jul 31, 2023

    Tuberculosis, Latent Tuberculosis Infection Trial in Bijie, Linping, Qingzhen (QuantiFERON-TB Gold (QFT) test)

    Recruiting
    • Tuberculosis
    • Latent Tuberculosis Infection
    • QuantiFERON-TB Gold (QFT) test
    • Bijie, Guizhou, China
    • +4 more
    Sep 12, 2023

    Tuberculosis Trial in H?i Phòng (Community based TB intervention)

    Not yet recruiting
    • Tuberculosis
    • Community based TB intervention
    • Hải Phòng, Vietnam
    • +1 more
    Dec 15, 2022

    Tuberculosis, Post-Tuberculous Pleural Fibrosis, Post-Tuberculous Bronchiectasis Trial in Peshawar (Experimental, Control)

    Recruiting
    • Tuberculosis
    • +2 more
    • Experimental
    • Control
    • Peshawar, KPK, Pakistan
      Green Star NGO
    Sep 14, 2023

    SARS-CoV-2 Disease on Immune Responses, Disease Severity and

    Recruiting
    • COVID-19 Respiratory Infection
    • Pulmonary Tuberculoses
      • Chennai, Tamilnadu, India
        National Institute for Research in Tuberculosis
      Jul 6, 2022

      Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet

      Recruiting
      • Tuberculosis
      • +2 more
      • Observational PK study
      • Kumasi, Ghana
        Kwame Nkrumah University of Science and Technology
      Dec 21, 2022

      COPD Trial (previous pulmonary tuberculosis)

      Not yet recruiting
      • COPD
      • previous pulmonary tuberculosis
      • (no location specified)
      Oct 5, 2023

      Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

      Not yet recruiting
      • Pulmonary Tuberculosis
      • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
      • +3 more
      • (no location specified)
      Jul 25, 2023

      COVID-19, Pulmonary Tuberculosis Trial in China (Standard dosage inactivated vaccine, Double dosage inactivated vaccine)

      Recruiting
      • COVID-19
      • Pulmonary Tuberculosis
      • Standard dosage inactivated vaccine
      • Double dosage inactivated vaccine
      • Huai'an, Jiangsu, China
      • +5 more
      Aug 12, 2022

      Tuberculosis Trial in Changsha (Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02), High-dose freeze-dried

      Recruiting
      • Tuberculosis
      • Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
      • +3 more
      • Changsha, Hunan, China
        Hunan Provincial Center for Disease Control and Prevention
      Sep 2, 2022

      Tuberculosis Trial in Abuja, Dasmariñas, Lusaka (Tongue swab-based molecular assays)

      Not yet recruiting
      • Tuberculosis
      • Tongue swab-based molecular assays
      • Abuja, Nigeria
      • +2 more
      Jul 11, 2023

      Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

      Not yet recruiting
      • Pulmonary TB
      • +2 more
      • Tbilisi, Georgia
      • +20 more
      Sep 22, 2023

      Tuberculosis, Pulmonary Trial in China (Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with

      Not yet recruiting
      • Tuberculosis, Pulmonary
      • Short Regimen with Rifapentine 10mg/kg
      • +3 more
      • Guiyang, Guizhou, China
      • +5 more
      May 28, 2022

      The INSTITUT Study

      Recruiting
      • Tuberculosis, Pulmonary
      • Undernutrition
      • Nutritional support
      • Porto-Novo, Benin
      • +1 more
      Oct 12, 2023

      Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for

      Not yet recruiting
      • Tuberculosis
      • Rifampicin Resistant Tuberculosis
      • Pretomanid
      • Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
      • Rio De Janeiro, Brazil
      • +6 more
      Oct 18, 2022

      HIV, Tuberculosis, Smoking Cessation Trial in Rondebosch (QUIT-AD, Enhanced Treatment as Usual)

      Not yet recruiting
      • HIV Infections
      • +2 more
      • QUIT-AD
      • Enhanced Treatment as Usual
      • Rondebosch, South Africa
        University of Cape Town
      Apr 24, 2023

      Gene Expression Profiles in Spinal Tuberculosis.

      Recruiting
      • Tuberculosis, Spinal
      • +13 more
        • Cape Town, Western Cape, South Africa
          Groote Schuur Hospital
        Nov 7, 2022